| Serum zinc and copper in people with COVID-19 and zinc supplementation in parenteral nutrition F Arrieta, V Martinez-Vaello, N Bengoa, L Jiménez-Mendiguchia, ... Nutrition 91, 111467, 2021 | 22 | 2021 |
| Safety and tolerability of inhaled antibiotics in patients with bronchiectasis M Vélez-Díaz-Pallarés, B Montero-Llorente, MÁ Parro-Martín, ... Pulmonary Pharmacology & Therapeutics 72, 102110, 2022 | 2 | 2022 |
| Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir LQ Muñoz, J Fernández-Fradejas, H Martinez-Barros, MS Cuervo, ... European Journal of Hospital Pharmacy, 2023 | 1 | 2023 |
| 5PSQ-042 Toxicity of remdesivir as treatment of non-critically ill COVID-19 patients L Quesada, J Fernández-Fradejas, HM Barros, MM Rufo, RP Recuenco, ... European Journal of Hospital Pharmacy 29 (Suppl 1), A132-A132, 2022 | 1 | 2022 |
| Deprescribing in older patients with advanced cancer referred to palliative care J Fernández-Fradejas, H Martínez-Barros, L Rexach-Cano, ... BMJ Supportive & Palliative Care, 2024 | | 2024 |
| 6ER-003 Assessment of overall survival and safety in newly approved oncohaematologic drugs ABP Fonseca, HM Barros, JP Bouzas European Journal of Hospital Pharmacy 31 (Suppl 1), A225-A225, 2024 | | 2024 |
| 6ER-031 Exclusion of people living with HIV from oncohaematological clinical trials with immune checkpoint inhibitors SR Tierno, HM Barros, JF Fradejas, MV Díaz-Pallarés, AMÁ Díaz European Journal of Hospital Pharmacy 31 (Suppl 1), A238-A239, 2024 | | 2024 |
| 4CPS-171 Methadone drug-drug interactions potentially related to cardiovascular events in clinical practice MR Marín, H Martinez-Barros, B Esteban-Cartelle, P Martin-Sanz, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A78-A79, 2023 | | 2023 |
| 6ER-010 Evolution of onco-haematological clinical trials from 2016 to 2021: experience from a tertiary hospital HM Barros, ÁD Gago, MR Marin, EG Lopez, CP López, ML Perez, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A163-A163, 2023 | | 2023 |
| 4CPS-101 Causality of adverse drug reactions in HIV-patients treated with bictegravir/emtricitabine/tenofovir alafenamide SJ Aguado, M Vélez-Díaz-Pallarés, AM Moreno-Zamora, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A56-A56, 2023 | | 2023 |
| Optimisation of the quality of care for patients with severe asthma: ASfarMA project M Muñoz-García, H Martínez-Barros, S Sánchez-Cuéllar, ... European Journal of Hospital Pharmacy, 2023 | | 2023 |
| 5PSQ-085 Real-world safety and tolerability of palbociclib as first-line therapy in patients with locally advanced or metastatic breast cancer HM Barros, M Sanchez-Cuervo, N Martinez-Jañez, AM Alvarez-Diaz European Journal of Hospital Pharmacy 29 (Suppl 1), A146-A147, 2022 | | 2022 |
| 5PSQ-203 Polypharmacy and potentially inappropriate medications in elderly oncohaematological patients referred to palliative care: application of the STOPPFrail criteria JF Fradejas, HM Barros, LR Cano, E Delgado-Silveira, AMÁ Díaz European Journal of Hospital Pharmacy 28 (Suppl 1), A155-A155, 2021 | | 2021 |
| ILAPHAR| Revista de la OFIL Revista de la Organización de Farmacéuticos| Ibero-latinoamericanos| Ibero Latin American Journal of Health System Pharmacy H Martínez-Barros, M Sánchez-Cuervo, NM Jáñez, AS García, ... | | |
Manuel Vélez-Díaz-PallarésHospital Universitario Ramón y CajalVerified email at salud.madrid.org
Manuel Vélez-Díaz-PallarésHospital Universitario Ramón y CajalVerified email at salud.madrid.org